Evaluating Adherence With the GOLD Guidelines for Treating Stage II (Moderate) COPD at a Single Tribal Facility

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Evaluating Adherence With the GOLD Guidelines for Treating Stage II (Moderate) COPD at a Single Tribal Facility

Article PDF
Author and Disclosure Information

Sharla R. Davis, PharmD; Stephanie D. Burns, PharmD; and Christopher M. Anoatubby, DPh.

Dr. Davis was the pharmacy resident for the Chickasaw Nation Division of Health at the time of this research and is currently the inpatient clinical pharmacy coordinator at the Chickasaw Nation Medical Center in Ada, Oklahoma. Dr. Burns is a clinical pharmacy coordinator and the residency program director at the Chickasaw Nation Medical Center. Dr. Anoatubby was the chief of pharmacy services for the Chickasaw Nation Division of Health at the time of this research and is now the chief medical solutions officer for the Chickasaw Nation Division of Commerce.

Issue
Federal Practitioner - 28(7)
Publications
Topics
Page Number
15
Legacy Keywords
National Heart, Lung, and Blood Institute, NHLBI, chronic obstructive pulmonary disease, COPD, tobacco use, Native American population, stage II COPD, Chickasaw Nation Health System, Global Initiative for Chronic Obstructive Lung Disease, GOLD, World Health Organization, American Thoracic Society, European Respiratory Society, pulmonary function tests, forced expiratory volume, Fev1, FVC, shortness of breath, chronic cough, putum production, long-acting inhaled bronchodilator, formoterol, salmeterol, tiotropium, B2-agonists, B2-adrenergic receptors, Classification of Diseases Ninth Revision Clinical Modification code, ICD-9-CM, electronic health record, EHR, respiratory therapy, smoking, short-acting inhaler, stage III COPD, stave IV COPDNational Heart, Lung, and Blood Institute, NHLBI, chronic obstructive pulmonary disease, COPD, tobacco use, Native American population, stage II COPD, Chickasaw Nation Health System, Global Initiative for Chronic Obstructive Lung Disease, GOLD, World Health Organization, American Thoracic Society, European Respiratory Society, pulmonary function tests, forced expiratory volume, Fev1, FVC, shortness of breath, chronic cough, putum production, long-acting inhaled bronchodilator, formoterol, salmeterol, tiotropium, B2-agonists, B2-adrenergic receptors, Classification of Diseases Ninth Revision Clinical Modification code, ICD-9-CM, electronic health record, EHR, respiratory therapy, smoking, short-acting inhaler, stage III COPD, stave IV COPD
Sections
Author and Disclosure Information

Sharla R. Davis, PharmD; Stephanie D. Burns, PharmD; and Christopher M. Anoatubby, DPh.

Dr. Davis was the pharmacy resident for the Chickasaw Nation Division of Health at the time of this research and is currently the inpatient clinical pharmacy coordinator at the Chickasaw Nation Medical Center in Ada, Oklahoma. Dr. Burns is a clinical pharmacy coordinator and the residency program director at the Chickasaw Nation Medical Center. Dr. Anoatubby was the chief of pharmacy services for the Chickasaw Nation Division of Health at the time of this research and is now the chief medical solutions officer for the Chickasaw Nation Division of Commerce.

Author and Disclosure Information

Sharla R. Davis, PharmD; Stephanie D. Burns, PharmD; and Christopher M. Anoatubby, DPh.

Dr. Davis was the pharmacy resident for the Chickasaw Nation Division of Health at the time of this research and is currently the inpatient clinical pharmacy coordinator at the Chickasaw Nation Medical Center in Ada, Oklahoma. Dr. Burns is a clinical pharmacy coordinator and the residency program director at the Chickasaw Nation Medical Center. Dr. Anoatubby was the chief of pharmacy services for the Chickasaw Nation Division of Health at the time of this research and is now the chief medical solutions officer for the Chickasaw Nation Division of Commerce.

Article PDF
Article PDF

Issue
Federal Practitioner - 28(7)
Issue
Federal Practitioner - 28(7)
Page Number
15
Page Number
15
Publications
Publications
Topics
Article Type
Display Headline
Evaluating Adherence With the GOLD Guidelines for Treating Stage II (Moderate) COPD at a Single Tribal Facility
Display Headline
Evaluating Adherence With the GOLD Guidelines for Treating Stage II (Moderate) COPD at a Single Tribal Facility
Legacy Keywords
National Heart, Lung, and Blood Institute, NHLBI, chronic obstructive pulmonary disease, COPD, tobacco use, Native American population, stage II COPD, Chickasaw Nation Health System, Global Initiative for Chronic Obstructive Lung Disease, GOLD, World Health Organization, American Thoracic Society, European Respiratory Society, pulmonary function tests, forced expiratory volume, Fev1, FVC, shortness of breath, chronic cough, putum production, long-acting inhaled bronchodilator, formoterol, salmeterol, tiotropium, B2-agonists, B2-adrenergic receptors, Classification of Diseases Ninth Revision Clinical Modification code, ICD-9-CM, electronic health record, EHR, respiratory therapy, smoking, short-acting inhaler, stage III COPD, stave IV COPDNational Heart, Lung, and Blood Institute, NHLBI, chronic obstructive pulmonary disease, COPD, tobacco use, Native American population, stage II COPD, Chickasaw Nation Health System, Global Initiative for Chronic Obstructive Lung Disease, GOLD, World Health Organization, American Thoracic Society, European Respiratory Society, pulmonary function tests, forced expiratory volume, Fev1, FVC, shortness of breath, chronic cough, putum production, long-acting inhaled bronchodilator, formoterol, salmeterol, tiotropium, B2-agonists, B2-adrenergic receptors, Classification of Diseases Ninth Revision Clinical Modification code, ICD-9-CM, electronic health record, EHR, respiratory therapy, smoking, short-acting inhaler, stage III COPD, stave IV COPD
Legacy Keywords
National Heart, Lung, and Blood Institute, NHLBI, chronic obstructive pulmonary disease, COPD, tobacco use, Native American population, stage II COPD, Chickasaw Nation Health System, Global Initiative for Chronic Obstructive Lung Disease, GOLD, World Health Organization, American Thoracic Society, European Respiratory Society, pulmonary function tests, forced expiratory volume, Fev1, FVC, shortness of breath, chronic cough, putum production, long-acting inhaled bronchodilator, formoterol, salmeterol, tiotropium, B2-agonists, B2-adrenergic receptors, Classification of Diseases Ninth Revision Clinical Modification code, ICD-9-CM, electronic health record, EHR, respiratory therapy, smoking, short-acting inhaler, stage III COPD, stave IV COPDNational Heart, Lung, and Blood Institute, NHLBI, chronic obstructive pulmonary disease, COPD, tobacco use, Native American population, stage II COPD, Chickasaw Nation Health System, Global Initiative for Chronic Obstructive Lung Disease, GOLD, World Health Organization, American Thoracic Society, European Respiratory Society, pulmonary function tests, forced expiratory volume, Fev1, FVC, shortness of breath, chronic cough, putum production, long-acting inhaled bronchodilator, formoterol, salmeterol, tiotropium, B2-agonists, B2-adrenergic receptors, Classification of Diseases Ninth Revision Clinical Modification code, ICD-9-CM, electronic health record, EHR, respiratory therapy, smoking, short-acting inhaler, stage III COPD, stave IV COPD
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media